Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
LBP AM's PFE Position: Q2 2026 in Review
LBP AM increased its Pfizer (PFE) stake by 100% in Q2 2026, buying an estimated $6.24M and bringing the position to 477,573 shares worth $11.5M. The position accounts for 0.11% of the portfolio, ranked #163.
LBP AM first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $25.3M in Q4 2025. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LBP AM held 477,573 shares of Pfizer worth $11.5M as of Q2 2026.
- LBP AM bought 238,366 Pfizer shares in Q2 2026, an estimated $6.24M.
- Pfizer made up 0.11% of LBP AM's portfolio in Q2 2026, its #163 holding.
- LBP AM first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- LBP AM's Pfizer position peaked at $25.3M in Q4 2025.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.